It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
https://arctichealth.org/en/permalink/ahliterature208936
Source
Diabetes Care. 1997 Apr;20(4):469-71
Publication Type
Article
Date
Apr-1997
More detail
Author
S M Haffner
Source
Diabetes Care. 1997 Apr;20(4):469-71
Date
Apr-1997
Language
English
Publication Type
Article
Keywords
Anticholesteremic Agents - therapeutic use
Cholesterol, HDL - blood
Coronary Disease - drug therapy - epidemiology - mortality - prevention & control
Diabetic Angiopathies - drug therapy - mortality - prevention & control
Gemfibrozil - therapeutic use
Humans
Hypolipidemic Agents - therapeutic use
Lovastatin - analogs & derivatives - therapeutic use
Multicenter Studies as Topic
Randomized Controlled Trials as Topic
Risk factors
Scandinavia
Simvastatin
Survival Rate
Triglycerides - blood
Notes
Comment On: Diabetes Care. 1997 Apr;20(4):614-209096989
PubMed ID
9096961
View in PubMed
Less detail
Permalink